Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson’s disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson’s disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging
Authors
Keywords
Positron emission tomography, Mouse models, Dopaminergics, Neurons, Parkinson disease, In vivo imaging, Animal models, Dopamine
Journal
PLoS One
Volume 12, Issue 3, Pages e0173503
Publisher
Public Library of Science (PLoS)
Online
2017-03-04
DOI
10.1371/journal.pone.0173503
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation of Parkinson Disease Severity and18F-DTBZ Positron Emission Tomography
- (2014) Ing-Tsung Hsiao et al. JAMA Neurology
- In Vivo Detection of Monoaminergic Degeneration in Early Parkinson Disease by 18F-9-Fluoropropyl-(+)-Dihydrotetrabenzazine PET
- (2013) S.-C. Lin et al. JOURNAL OF NUCLEAR MEDICINE
- Therapeutic Effects of Rapamycin on MPTP-Induced Parkinsonism in Mice
- (2012) Kangyong Liu et al. NEUROCHEMICAL RESEARCH
- PET Imaging a MPTP-Induced Mouse Model of Parkinson’s Disease Using the Fluoropropyl-Dihydrotetrabenazine Analog [18F]-DTBZ (AV-133)
- (2012) James S. Toomey et al. PLoS One
- Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([18F]AV-133) in a MPTP-lesioned PD mouse model
- (2012) Ko-Ting Chao et al. SYNAPSE
- Protective and Restorative Effects of Magnolol on Neurotoxicity in Mice with 6-Hydroxydopamine-Induced Hemiparkinsonism
- (2011) Hwei-Hsien Chen et al. Neurodegenerative Diseases
- Optimal scanning time window for 18F-FP-(+)-DTBZ (18F-AV-133) summed uptake measurements
- (2011) Kun-Ju Lin et al. NUCLEAR MEDICINE AND BIOLOGY
- Current approaches to the treatment of Parkinson’s disease
- (2011) Joseph Jankovic Neuropsychiatric Disease and Treatment
- Functional models of Parkinson's disease: A valuable tool in the development of novel therapies
- (2010) Peter Jenner ANNALS OF NEUROLOGY
- Age-specific progression of nigrostriatal dysfunction in Parkinson's disease
- (2010) Raúl de la Fuente-Fernández et al. ANNALS OF NEUROLOGY
- In Vivo Measurement of Vesicular Monoamine Transporter Type 2 Density in Parkinson Disease with 18F-AV-133
- (2010) N. Okamura et al. JOURNAL OF NUCLEAR MEDICINE
- Whole-Body Biodistribution and Radiation Dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): A Novel Vesicular Monoamine Transporter 2 Imaging Agent
- (2010) K.-J. Lin et al. JOURNAL OF NUCLEAR MEDICINE
- Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats
- (2010) Hsin-Hsin Tsao et al. NUCLEAR MEDICINE AND BIOLOGY
- Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice
- (2009) Nobuaki Matsui et al. BRAIN RESEARCH
- Validation of 4-[18F]-ADAM as a SERT imaging agent using micro-PET and autoradiography
- (2009) Kuo-Hsing Ma et al. NEUROIMAGE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started